Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening [...]
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a [...]
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, [...]
Prosecute Trump, Despite the Risks?
Readers react to an editorial urging an indictment to show [...]
Covid Vaccine and Fisheries Deals Close a ‘Roller Coaster’ W.T.O. Meeting
Members of the global trade group were forced to scale [...]
Omicron Is Here. Will We Use Our New Covid Drugs Wisely?
The world must not repeat history by making Covid-19 drugs [...]
Here’s Why Developing Countries Can Make mRNA Covid Vaccines
Pfizer and Moderna are skeptical, but we found 10 companies [...]
Pressure Grows on U.S. Companies to Share Covid Vaccine Technology
Moderna accepted $2.5 billion in taxpayer money to develop its [...]